EPIGENE.COM

Serial Number 85202806
606

Registration Progress

Application Filed
Dec 21, 2010
Under Examination
Jul 12, 2011
Approved for Publication
May 18, 2011
Published for Opposition
May 17, 2011
Registered

Trademark Image

EPIGENE.COM

Basic Information

Serial Number
85202806
Filing Date
December 21, 2010
Published for Opposition
May 17, 2011
Abandonment Date
February 13, 2012
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Feb 13, 2012
Classes
005

Rights Holder

Epigenesis Pharmaceuticals, LLC

16
Address
2009 Eastpark Boulevard
Cranbury, NJ 08512

Ownership History

Epigenesis Pharmaceuticals, LLC

Original Applicant
16
Cranbury, NJ

Epigenesis Pharmaceuticals, LLC

Owner at Publication
16
Cranbury, NJ

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

21 events
Date Code Type Description Documents
Mar 9, 2012 UNDN O UNDELIVERABLE MAIL - NO ACTION TAKEN Loading...
Feb 13, 2012 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Feb 13, 2012 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Jul 26, 2011 UNDN O UNDELIVERABLE MAIL - NO ACTION TAKEN Loading...
Jul 22, 2011 UNDN O UNDELIVERABLE MAIL - NO ACTION TAKEN Loading...
Jul 12, 2011 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 18, 2011 NPUB O NOTICE OF PUBLICATION Loading...
May 17, 2011 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 5, 2011 WOAR I TEAS WITHDRAWAL OF ATTORNEY RECEIVED Loading...
May 5, 2011 WOAG I WITHDRAWAL OF ATTORNEY GRANTED Loading...
Apr 9, 2011 ALIE A ASSIGNED TO LIE Loading...
Apr 9, 2011 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Mar 29, 2011 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 29, 2011 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Mar 29, 2011 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 29, 2011 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 29, 2011 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 21, 2011 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 31, 2010 MPMK O NOTICE OF PSEUDO MARK MAILED Loading...
Dec 30, 2010 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 24, 2010 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
medical diagnostic and therapeutic preparations, all for administration via diverse routes of administration including through the respiratory airways, and, medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, impeded respiration, acute respiratory disease syndrome (ards), renal damage and failure, ischemia resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating supra ventricular tachycardia (svt), adenosine stress tests, infantile respiratory distress syndrome (infantile rds), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasconcontriction, emphysema, chronic obstructive pulmonary disease (copd), as well as cancers including leukemias, lymphomas, carcinomas, and the like, e.g., colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as metastatic cancers, e.g., cancers which metastasized to the lung(s), breast, liver and prostate
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Pseudo Mark
EPIGENESIS

Classification

International Classes
005